Home
关于我们
产品中心
新闻资讯
技术文章
定制合成
联系我们
中文
产品中心
PRODUCTS
Current location:
Home
>>
产品中心
>>
抗体
PRODUCT CLASSIFICATION
News
NEWS
Application of bioactive small molecules in disease research
Green intelligence creates industry trends, Fuzhen Biology promotes low-carbon development of fine chemical industry
The monoclonal antibody industry is developing rapidly, and Fuzhen Biotechnology is improving its supply system for monoclonal antibody related raw materials
The global biopharmaceutical market continues to expand
Molecular building blocks are used as accelerators for the development of new drugs
Structural formula
Art.No.
Name
CAS
Pureness
CFZ03118
Research Grade Cergutuzumab
1509916-03-3
95%
CFZ03117
Pepinemab
2097151-87-4
95%
CFZ03116
Research Grade Nemolizumab
1476039-58-3
95%
CFZ03115
Andecaliximab
1518996-49-0
95%
CFZ03114
Monalizumab
1228763-95-8
95%
CFZ03113
Brolucizumab
1531589-13-5
95%
CFZ03112
Istiratumab
1509928-04-4
95%
CFZ03111
Opicinumab
1422268-07-2
95%
CFZ03110
Indusatumab Vedotin
1514889-12-3
95%
CFZ03107
Ascrinvacumab
1463459-96-2
95%
Home
<<
···
5
6
7
8
9
···
7/59
>>
Last
QQ
QQ
Service Hotline:
15111215862
18229892877